Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | Circulating DNA testing commercially available

Samreen Ahmed • 31 Jan 2020
BTOG 2020
Lung Cancer

Samreen Ahmed, FRCP, MD, University Hospitals of Leicester, UK, discusses the commercial availability of circulating DNA testing and how this can aid treatment with the detection of actionable genetic targets. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

More from Samreen Ahmed

3:29
Novel strategies to treating brain metastases in lung cancer
Samreen Ahmed • 27 Mar 2023
0:54
Early lung cancer at ELCC 2023
Samreen Ahmed • 27 Mar 2023
0:55
Management of brain metastases associated with lung cancer
Samreen Ahmed • 27 Mar 2023
3:06
Highlights from the BTOG 2023 therapeutics symposium
Samreen Ahmed • 26 Apr 2023

Related Videos

0:37
STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC
Clive Peedell • 18 Apr 2024
0:44
BTOG 2024: networking highlights and insights
Clive Peedell • 18 Apr 2024
0:49
Ongoing trials in thoracic radiotherapy: evaluating current role and significance
Thomas Newsom-Davis • 18 Apr 2024
4:20
Insights from BTOG 2024: advancements in TNM Staging, systematic staging, & immunotherapy strategies
Thomas Newsom-Davis • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals